controversy about the NEW cardiovascular risk calculator

January 2014

You'll also hear controversy about the NEW cardiovascular risk calculator. It's part of the new Am Heart Assn cholesterol guidelines.

It determines a patient's 10-year risk of a heart attack or stroke based on their sex, age, race, total and HDL cholesterol, diabetes, systolic BP, hypertension treatment, and smoking status.

Critics will say that it sometimes under- or overestimates risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology new cholesterol guidelines that focus MORE on statins...LESS on non-statins...and ABANDON LDL goals
Cardiology controversy about the NEW cardiovascular risk calculator
Controlled Substances Pharmacists will play an even bigger role in preventing the misuse and abuse of controlled substances
COPD more focus on improving management of COPD in an effort to reduce hospital admissions
Diabetes The Avandia (rosiglitazone) debate will heat up again now that FDA will loosen its restrictions
Diabetes Sliding scale insulin is still giving patients a ride on the blood glucose roller coaster
Interactions kidney problems when clarithromycin is combined with a calcium channel blocker (amlodipine, etc)
Women's Health whether levonorgestrel emergency contraceptives (Plan B One-Step, etc) are effective in heavier women
Women's Health using ondansetron for morning sickness
Pediatrics using SSRIs for depression and anxiety in children and adolescents
Supplements "relaxation drinks"
Healthy Lifestyles New lifestyle guidelines will help patients with New Year's resolutions to improve their health and lower cardiovascular risk

controversy about the NEW cardiovascular risk calculator

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents